Examining the prior authorization process, patient outcomes, and the impact of a pharmacy intervention: A single-center review

Abstract Background Dermatology experiences a disproportionately high burden of prior authorizations (PAs). Objective To examine the effect of a centralized pharmacy intervention on the PA process and the impact of PAs on patient outcomes. Methods Retrospective review of PAs submitted for medications before and after implementation of pharmacy intervention was conducted. Results 8.1% of all prescriptions required PA. PAs were most frequently submitted for topical steroids, topical antibiotics and antifungals, and topical retinoids. Most common indications included acne, psoriasis, and dermatitis. Biologics (55.2%) and brand-name only medications (42.8%) required PA at higher rates. Pharmacy intervention resulted in shorter time to PA submission (4 days vs. 1 day, p Limitations Data were collected from a single academic institution. Patient medication compliance was not assessed. Conclusion The current PA process may result in delays in care and a negative impact on patients. A centralized pharmacy intervention is an effective measure but does not eliminate the overall burden of PAs.